ArticleEuropean journal of medical research2026
Relationship between infection or inflammation of prostate and risk of prostate cancer: a cross-sectional population-based study.
Article in European journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe association between infection or inflammation of prostate and the risk of prostate cancer (PCa) remains a contentious issue. This article aims to assess the relationship between infection or inflammation of prostate and the risk of PCa.
methodsWe performed a cross-sectional study utilizing the 2001-2010 National Health and Nutrition Examination Survey data. The dataset encompasses 7,981 male participants from the United States with an age exceeding 40 years. Weighted statistical population descriptors, univariate analysis, and multivariate regression analysis were employed for the analysis. Subgroup analyses were conducted to further validate the stability of this association across different groups.
resultsThe results revealed that individuals with infection or inflammation of the the prostate had a hazard ratio of 4.0 for developing PCa compared to those without such history, indicating a 300% increased risk of PCa (OR = 4.0; 95% CI: 1.1, 10.6; P < 0.001). After adjusting for confounding factors, individuals with infection or inflammation of prostate still exhibited a significant hazard ratio of 2.8 for developing PCa compared to those without such conditions, representing a 180% increased risk (OR = 2.8; 95% CI: 1.3, 6.1; P = 0.011); subgroup analysis demonstrated that within the age range of > = 40 and < 60 years, individuals with infection or inflammation of prostate had a hazard ratio of 2.8 for developing PCa, signifying a 180% heightened risk of PCa (OR = 2.8; 95% CI: 1.4, 5.1; P = 0.004); within the age range of > = 60 years, individuals with infection or inflammation of prostate had a hazard ratio of 5.0 for developing PCa, indicating a 400% increased risk of PCa (OR = 5.0; 95% CI: 1.3, 19.0; P = 0.020).
conclusionThis study indicates that among American males aged over 40, those with infection or inflammation of the the prostate exhibit an increased risk of developing PCa, particularly in the older age group (age > = 60), and this association remains significant even after adjusting for pertinent confounding factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.